IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01524978A Study of Zelboraf (Vemurafenib) in Patients With BRAF V600 Mutation-Positive Cancers